Abbott looks to ‘highly productive’ device pipeline for future growth

CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the recently approved Triclip valve a “billion-dollar opportunity."

Lilly obesity drug shows benefit in sleep disorder study, pointing to new use

Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.

Files taken from Orasure systems in cybersecurity incident

Orasure believes it has contained the incident and “preserved the integrity of its core financial and operational systems.”

FDA warns Soulaire to stop selling device outside authorized uses

Soulaire marketed its external counterpulsation system to grow new arteries, repair organ dysfunction and treat COVID-19, among other uses, without evidence.

‘We think in decades’: J&J’s $30B spending spree may not be over

After Johnson & Johnson has doled out more than $30 billion for Abiomed, Laminar and Shockwave Medical, are more medtech deals on the way?

Solventum appoints Shirley Edwards to board of directors

The 3M spinoff highlighted Edwards’ expertise in mergers and acquisitions and corporate governance as an asset.

GE Healthcare imaging CEO to resign

Jan Makela plans to leave the company in July to join another firm.

Edwards pushes back on Medtronic’s head-to-head TAVR trial

Edwards Lifesciences and Wall Street analysts questioned the results of Medtronic’s women-focused study, claiming the data are inconsistent with real-world evidence.

Abbott’s latest Heartmate recall tied to 273 injuries, 14 deaths

Biological material can build up and obstruct blood flow in heart failure patients supported by the left ventricular assist devices, the FDA said.

Exact Sciences names Aaron Bloomer CFO

The executive will succeed Jeff Elliott, who said in January he would step down due to personal reasons.